Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChAdOx1 85A Aerosol vs IM in Healthy Adults
NCT04121494Phase 1Completed
- Start
- Jan 2019
- Primary completion
- Aug 2020
- Modality
- Viral Vector Vaccines
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ChAdOx1 85A in Tuberculosis (TB) (6 arms). Primary endpoint: Safety - (serious) adverse events. Started Jan 2019; status: completed.
02
Drugs
ChAdOx1 85A
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT04121494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04121494.